COMMUNIQUÉS West-GlobeNewswire
-
GENFIT: OUTCOME OF THE ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING OF JUNE 16, 2017
16/06/2017 - 17:46 -
Diaxonhit : Assemblée générale ordinaire et extraordinaire annuelle
16/06/2017 - 17:45 -
FDA posts briefing materials prior to Advisory Committee meeting for Victoza® label update
16/06/2017 - 14:28 -
Kymab Group Ltd: Kymab appoints Dr Martin Nicklasson as Non-Executive Chair
16/06/2017 - 10:00 -
Bavarian Nordic Announces Notification of Request for Proposal for Freeze-Dried IMVAMUNE
16/06/2017 - 09:26 -
Helsinn Investment Fund leads the financial round in GreenBone
16/06/2017 - 09:25 -
RECORDATI LICENSES AN INNOVATIVE TREATMENT FOR NEUROTROPHIC KERATITIS
16/06/2017 - 08:33 -
Annual General Meeting of Active Biotech AB
16/06/2017 - 08:30 -
Bavarian Nordic Provides Update on Anticipated Timing of PROSPECT Study
16/06/2017 - 07:30 -
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
16/06/2017 - 07:00 -
Idorsia - Reaching out for more
16/06/2017 - 07:00 -
Johnson & Johnson Completes Acquisition of Actelion
16/06/2017 - 07:00 -
DBV Technologies annonce la nomination de Julie O'Neill au conseil d'administration
15/06/2017 - 22:30 -
DBV Technologies Announces Appointment of Julie O'Neill to Board of Directors
15/06/2017 - 22:30 -
DBV Technologies Annonce les Résultats de son Assemblée Générale Mixte 2017
15/06/2017 - 22:30 -
DBV Technologies Announces Results of its 2017 Ordinary and Extraordinary General Meeting
15/06/2017 - 22:30 -
NANOBIOTIX a présenté de nouvelles données translationnelles lors du workshop d'Immunothérapie organisé par l'ASTRO, le NCI et le SITC
15/06/2017 - 21:43 -
NANOBIOTIX : new translational data presented at ASTRO, NCI AND SITC'S Immunotherapy Workshop
15/06/2017 - 21:43 -
FDA accepts Sandoz regulatory submission for a generic version of Advair Diskus®
15/06/2017 - 20:00
Pages